Table 3.

Use of other therapies before and after the index date

Variable	Group	Before Exclusion Period, Mean (SE)	After Exclusion Period, Mean (SE)	p*	p*
Oral antibiotics (percent of encounters)	MARPA+ MARPA-	5.87% (0.4%) 7.37% (0.33%)	18.43% (0.97%) 18.18% (0.57%)	<0.001 <0.001	0.14
Inhaled antibiotics (percent of encounters)	MARPA+ MARPA-	22.46% (0.76%) 18.80% (0.45%)	39.54% (1.05%) 36.75% (0.65%)	<0.001 <0.001	0.44
Oral corticosteroids (percent of encounters)	MARPA+ MARPA-	13.86% (0.82%) 10.49% (0.46%)	15.89% (0.92%) 11.98% (0.50%)	0.016 0.002	0.58
Enteral supplements (percent of encounters)	MARPA+ MARPA-	12.19% (1.01%) 7.41% (0.51%)	18.69% (1.18%) 11.85% (0.64%)	<0.001 <0.001	0.051
Insulin/oral hypoglycemic (percent of encounters)	MARPA+ MARPA-	0.12% (0.05%) 0.19% (0.04%)	4.08% (0.53%) 3.51% (0.33%)	<0.001 <0.001	0.28
Dornase alfa (percent of encounters)	MARPA+ MARPA-	75.70% (1.18%) 65.62% (0.83%)	80.75% (1.06%) 74.65% (0.75%)	<0.001 <0.001	0.002
Oxygen (percent of patients ever)	MARPA+ MARPA-	17.37% (1.14%) 8.09% (0.48%)	29.43% (1.37%) 15.66% (0.64%)	<0.001 <0.001	0.002

SE, standard error.

^*Compares before to after within MARPA group.

^*Compares difference between MARPA groups.